Literature DB >> 26334315

The role of ion channels in malignant brain tumors.

Ole J Simon1, Thomas Müntefering2, Oliver M Grauer2, Sven G Meuth2.   

Abstract

Malignant gliomas are the most common primary brain tumors and have poor clinical prognosis, despite multimodal therapeutic strategies. In recent years, ion channels have emerged as major players in tumor pathophysiology regarding all hallmarks of cancer. Since ion channels are easily accessible structures, they may prove to be effective targets for canner therapy, although their broad expression pattern and role in physiological processes should be taken into consideration. This review summarizes the current knowledge on the role of ion channels in the pathophysiology of malignant gliomas, especially glioblastoma, and evaluates their potential role in targeted antiglioma therapy.

Entities:  

Keywords:  Brain tumor; Ion channels; Malignant glioma; Tumor cells

Mesh:

Substances:

Year:  2015        PMID: 26334315     DOI: 10.1007/s11060-015-1896-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  62 in total

1.  BK channels in human glioma cells have enhanced calcium sensitivity.

Authors:  Christopher B Ransom; Xiaojin Liu; Harald Sontheimer
Journal:  Glia       Date:  2002-06       Impact factor: 7.452

2.  Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells.

Authors:  Jehad Algharabil; Douglas B Kintner; Qiwei Wang; Gulnaz Begum; Paul A Clark; Sung-Sen Yang; Shih-Hua Lin; Kristopher T Kahle; John S Kuo; Dandan Sun
Journal:  Cell Physiol Biochem       Date:  2012-06-08

3.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

4.  Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer.

Authors:  J Bielanska; J Hernández-Losa; M Pérez-Verdaguer; T Moline; R Somoza; S Ramón Y Cajal; E Condom; J C Ferreres; A Felipe
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

5.  Inhibition of T-type Ca²⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration.

Authors:  Yuan Zhang; Junhong Zhang; Dongsheng Jiang; Dong Zhang; Zhiyuan Qian; Chunfeng Liu; Jin Tao
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  The role of matrix metalloproteinases in glioma invasion.

Authors:  Mitsutoshi Nakada; Yasunori Okada; Junkoh Yamashita
Journal:  Front Biosci       Date:  2003-01-01

7.  Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3.

Authors:  Vishnu Anand Cuddapah; Kathryn L Turner; Stefanie Seifert; Harald Sontheimer
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

9.  Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.

Authors:  Ming Yang; David J Kozminski; Lindsey A Wold; Rohan Modak; Jeffrey D Calhoun; Lori L Isom; William J Brackenbury
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

10.  KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.

Authors:  G D'Alessandro; M Catalano; M Sciaccaluga; G Chece; R Cipriani; M Rosito; A Grimaldi; C Lauro; G Cantore; A Santoro; B Fioretti; F Franciolini; H Wulff; C Limatola
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

View more
  3 in total

Review 1.  Ion Channels and Their Role in the Pathophysiology of Gliomas.

Authors:  Takeshi Takayasu; Kaoru Kurisu; Yoshua Esquenazi; Leomar Y Ballester
Journal:  Mol Cancer Ther       Date:  2020-10       Impact factor: 6.261

2.  Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.

Authors:  Julia Pollak; Karan G Rai; Cory C Funk; Sonali Arora; Eunjee Lee; Jun Zhu; Nathan D Price; Patrick J Paddison; Jan-Marino Ramirez; Robert C Rostomily
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

Review 3.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.